Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
Evron E, Ben-David AM, Goldberg H, Fried G, Kaufman B, Catane R, Pfeffer MR, Geffen DB, Chernobelsky P, Karni T, Abdah-Bortnyak R, Rosengarten O, Matceyevsky D, Inbar M, Kuten A, Corn BW.
Evron E, et al.
Ann Oncol. 2019 Mar 1;30(3):412-417. doi: 10.1093/annonc/mdy515.
Ann Oncol. 2019.
PMID: 30475942
Free article.
Clinical Trial.
PATIENTS AND METHODS: In this Institutional Review Board-approved phase II trial, the option of prophylactic irradiation to the contralateral breast, in addition to standard loco-regional treatment, was offered to BRCA carrier patients treated for early breast cancer who d …
PATIENTS AND METHODS: In this Institutional Review Board-approved phase II trial, the option of prophylactic irradiation to the contralatera …